Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001522780-26-000002

Director acquired 61,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kaye Edward M. MD Director 2026-03-15 Option exercise +35,500 84,624 D: show line 1 in the form
Kaye Edward M. MD Director 2026-03-15 Option exercise +26,250 110,874 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kaye Edward M. MD Director 2026-03-15 Option exercise · Restricted Stock Units −35,500 35,500 D: show line 3 in the form
Kaye Edward M. MD Director 2026-03-15 Option exercise · Restricted Stock Units −26,250 52,500 D: show line 4 in the form
Loading xslF345X05/form4-03172026_090329.xml…